Adjuvant chemotherapy for completely resected non-small cell lung cancer with TS-1 [S 1] - evaluation of predictive factors for prognosis

Trial Profile

Adjuvant chemotherapy for completely resected non-small cell lung cancer with TS-1 [S 1] - evaluation of predictive factors for prognosis

Recruiting
Phase of Trial: Phase II

Latest Information Update: 27 Mar 2012

At a glance

  • Drugs Gimeracil/oteracil/tegafur (Primary)
  • Indications Non-small cell lung cancer
  • Focus Therapeutic Use
  • Acronyms KOLK-2
  • Most Recent Events

    • 27 Mar 2012 Planned End Date changed from 1 Feb 2015 to 1 Oct 2017 as reported by University Hospital Medical Information Network - Japan.
    • 27 Mar 2012 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan.
    • 26 May 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top